Skip to main content

Table 2 Different adjuvant chemotherapeutic regimes used in treatment of patients with LCNEC

From: Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas

Chemotherapeutic regime

N

SCLC-based regimes

 Cisplatin/etoposide

11

 Carboplatin/etoposide

5

NSCLC-based regimes

 Carboplatin/paclitaxel

3

 Carboplatin/gemcitabine

1

 Carboplatin/vinorelbine

3

 Cisplatin/permetrexed

1

 Cisplatin/vinorelbine

5

 Cisplatin/doxetaxel

2

 Gemcitabine

1

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us